Effects of Perianal Involvement on Clinical Outcomes in Crohn’s Disease over 10 Years
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: There was the assumption that Crohn’s disease (CD) patients with perianal lesions might have different clinical courses compared to those without. However, quantifiable data comparing the long-term outcomes between the two groups are scarce. Methods: We retrospectively reviewed 221 consecutive patients newly diagnosed with CD and registered at the IBD clinic of Severance Hospital, in Seoul, Korea, between January 1990 and October 2005. We compared patients with perianal CD (PCD) and non-perianal CD (NPCD) in terms of clinical outcomes over 10 years. Results: PCD progressed more frequently from inflammatory to complicated behavior than NPCD. Moreover, corticosteroids were prescribed in 102 patients with PCD and only 57 with NPCD (82.9% vs 58.2%, p<0.001), immunosuppressants in 89 and 42 (72.4% vs 42.9%, p<0.001), and anti-tumor necrosis factor α (TNF-α) in 37 and 12 (30.1% vs 12.2%, p=0.002). Cumulative hospitalization rates were 82.1% in PCD and 72.4% in NPCD (p=0.086), and surgical intervention rates were 39.8% and 51.0%, respectively (p=0.097). Conclusions: Patients with PCD were more likely than those with NPCD to be administered corticosteroids, immunosuppressants, and anti-TNF-α. However, there is no significant difference in the cumulative rates of surgical interventions or hospitalizations.
Abstract
Background/Aims: There was the assumption that Crohn’s disease (CD) patients with perianal lesions might have different clinical courses compared to those without. However, quantifiable data comparing the long-term outcomes between the two groups are scarce. Methods: We retrospectively reviewed 221 consecutive patients newly diagnosed with CD and registered at the IBD clinic of Severance Hospital, in Seoul, Korea, between January 1990 and October 2005. We compared patients with perianal CD (PCD) and non-perianal CD (NPCD) in terms of clinical outcomes over 10 years. Results: PCD progressed more frequently from inflammatory to complicated behavior than NPCD. Moreover, corticosteroids were prescribed in 102 patients with PCD and only 57 with NPCD (82.9% vs 58.2%, p<0.001), immunosuppressants in 89 and 42 (72.4% vs 42.9%, p<0.001), and anti-tumor necrosis factor α (TNF-α) in 37 and 12 (30.1% vs 12.2%, p=0.002). Cumulative hospitalization rates were 82.1% in PCD and 72.4% in NPCD (p=0.086), and surgical intervention rates were 39.8% and 51.0%, respectively (p=0.097). Conclusions: Patients with PCD were more likely than those with NPCD to be administered corticosteroids, immunosuppressants, and anti-TNF-α. However, there is no significant difference in the cumulative rates of surgical interventions or hospitalizations.
참고문헌 (36)
- Steinhart AH, "Reliability of a Crohn's disease clinical classification scheme based on disease behavior", Inflamm Bowel Dis, 4, pp.228~234 (1998)[DOI]
- Gasche C, "A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998", Inflamm Bowel Dis, 6, pp.8~15 (2000)[DOI]
- Cosnes J, "Long-term evolution of disease behavior of Crohn's disease", Inflamm Bowel Dis, 8, pp.244~250 (2002)[DOI]
- Louis E, "Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease", Gut, 49, pp.777~782 (2001)[DOI]
- Sachar DB, "Is perianal Crohn's disease associated with intestinal fistulization?", Am J Gastroenterol, 100, pp.1547~1549 (2005)[DOI]
- Silverberg MS, "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology", Can J Gastroenterol, 19(Suppl A), pp.5A~36A (2005)[DOI]
- Tarrant KM, "Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype", Am J Gastroenterol, 103, pp.3082~3093 (2008)[DOI]
- Eglinton T, "Ileal disease is associated with surgery for perianal disease in a population-based Crohn's disease cohort", Br J Surg, 97, pp.1103~1109 (2010)[DOI]
- Beaugerie L, "Predictors of Crohn's disease", Gastroenterology, 130, pp.650~656 (2006)[DOI]
- Eglinton TW, "Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort", Am J Gastroenterol, 107, pp.589~596 (2012)[DOI]
- Nasir BF, "Perianal disease combined with NOD2 genotype predicts need for IBD-related surgery in Crohn's disease patients from a population-based cohort", J Clin Gastroenterol, 47, pp.242~245 (2013)[DOI]
- Kaur M, "Perianal Crohn's disease is associated with distal colonic disease, stricturing disease behavior, IBD-associated serologies and genetic variation in the JAK-STAT pathway", Inflamm Bowel Dis, 22, pp.862~869 (2016)[DOI]
- Eglinton TW, "The spectrum of perianal Crohn's disease in a population-based cohort", Dis Colon Rectum, 55, pp.773~777 (2012)[DOI]
- Ingle SB, "The natural history of perianal Crohn's disease", Dig Liver Dis, 39, pp.963~969 (2007)[DOI]
- Schwartz DA, "The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota", Gastroenterology, 122, pp.875~880 (2002)[DOI]
- Ye BD, "Clinical features and long-term prognosis of Crohn's disease in Korea", Scand J Gastroenterol, 45, pp.1178~1185 (2010)[DOI]
- Moon CM, "Clinical features and predictors of clinical outcomes in Korean patients with Crohn's disease: a Korean association for the study of intestinal diseases multicenter study", J Gastroenterol Hepatol, 29, pp.74~82 (2014)[DOI]
- Han YM, "Patients with perianal Crohn's disease have poor disease outcomes after primary bowel resection", J Gastroenterol Hepatol, 31, pp.1436~1442 (2016)[DOI]
- Thia KT, "Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort", Gastroenterology, 139, pp.1147~1155 (2010)[DOI]
- Loftus EV Jr, "Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival", Gastroenterology, 114, pp.1161~1168 (1998)[DOI]
- American Gastroenterological Association Clinical Practice Committee, "American Gastroenterological Association medical position statement: perianal Crohn's disease", Gastroenterology, 125, pp.1503~1507 (2003)[DOI]
- Satsangi J, "The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications", Gut, 55, pp.749~753 (2006)[DOI]
- Hanauer SB, "Crohn's disease: step up or top down therapy", Best Pract Res Clin Gastroenterol, 17, pp.131~137 (2003)[DOI]
- Tang LY, "Are perineal and luminal fistulas associated in Crohn's disease? A population-based study", Clin Gastroenterol Hepatol, 4, pp.1130~1134 (2006)[DOI]
- Lapidus A, "Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients", Gastroenterology, 114, pp.1151~1160 (1998)[DOI]
- 송인성, "크론병에서 항문 주위 병변의 임상상과 치료에 대한 반응", 대한소화기학회지, 42(2) (2003), 대한소화기학회
- Kim JY, "The incidence and natural history of perianal fistulas in Korean patients with Crohn's disease", Intest Res, 4, pp.22~31 (2006)
- Chow DK, "Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system", Inflamm Bowel Dis, 14, pp.536~541 (2008)[DOI]
- Leong RW, "The epidemiology and phenotype of Crohn's disease in the Chinese population", Inflamm Bowel Dis, 10, pp.646~651 (2004)[DOI]
- Dorn SD, "Clinical characteristics of familial versus sporadic Crohn's disease using the Vienna Classification", Inflamm Bowel Dis, 10, pp.201~206 (2004)[DOI]
- Veloso FT, "Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity", Inflamm Bowel Dis, 7, pp.306~313 (2001)[DOI]
- Smith BR, "Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2", CARD15 genotype influence the progression of disease behavior in Crohn's disease, 2004, pp.10, 521~528
- Kanaan Z, "Perianal Crohn's disease: predictive factors and genotypephenotype correlations", Dig Surg, 29, pp.107~114 (2012)[DOI]
- Eglinton TW, "Clinical factors predicting disease course in Crohn's disease", Expert Rev Clin Immunol, 6, pp.41~45 (2010)[DOI]
- Bernell O, "Risk factors for surgery and postoperative recurrence in Crohn's disease", Ann Surg, 231, pp.38~45 (2000)[DOI]
- Oriuchi T, "Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality", J Gastroenterol, 38, pp.942~953 (2003)[DOI]